All you need to know about NCI, CDISC and SDTM controlled terminology Blog Post
The use of controlled terminology (CT) is vital to successful clinical study build. In clinical trials, CT can be referred to in several different ways, such as: While these terms…
Model-Informed Confidence in Oncology Dose Selection Blog Post
Discover an oncology-focused company that gained confidence in their dose selection for an AML trial with pediatric patients and reduced their clinical development costs, by using mechanistic modeling. Sutro is...
Phoenix™ PK/PD Platform Page
The industry’s most trusted PK/PD platform for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more.
Certara’s MIDD Oncology Capabilities Blog Post
Transcript: The pace of oncology drug development is moving at the speed of life. Approvals are trending up, giving cancer patients more treatment options to stay ahead in their fight…
Certara’s AI Answer to Medical Writing Challenges in Pharma Blog Post
Medical writing is a complex and regulated process that requires compliance with guidelines from health authorities such as the FDA and EMA. Generative Pre-trained Transformers (GPTs) can generate human-like text…
A guide to CDISC standards used in clinical research Blog Post
An overview of CDISC standards in the clinical research process. Learn about content standards, data exchange standards, and other CDISC resources.
